Patients at risk of onychomycosis - Risk factor identification and active prevention

Antonella Tosti, R. Hay, R. Arenas-Guzmán

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Objectives: The aims of this workshop were to identify risk factors for onychomycosis and to reach consensus on the management of high-risk groups to allow the development of guidelines to help doctors recognize risk factors that complicate treatment. Results and Conclusions: Previous Trichophyton rubrum infection, older age, abnormal nail morphology, immunodeficiency and genetic factors were identified as risk factors for initial infections. Risk factors for recurrence (relapse and re-infection) are largely the same. The experts agreed that the prevention of onychomycosis and its recurrence should be based on the correct treatment of tinea pedis, screening family members and adequate patient education. In addition, generic management recommendations for each high-risk group were discussed: Immunosuppressed patients Usual dose and treatment length not appropriate Follow-up required Beware of drug interactions Diabetics Prophylactic foot care combined with nail treatment Good opportunity for patient education, footwear, foot care, etc. Beware of drug interactions Psoriatics and patients with abnormal nails Dermatophyte eradication does not restore normal nails Children High failure rate possibly due to compliance problems.

Original languageEnglish
Pages (from-to)13-16
Number of pages4
JournalJournal of the European Academy of Dermatology and Venereology
Volume19
Issue numberSUPPL. 1
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Fingerprint

Onychomycosis
Malformed Nails
Patient Education
Nails
Drug Interactions
Recurrence
Tinea Pedis
Arthrodermataceae
Diabetic Foot
Risk Management
Therapeutics
Infection
Compliance
Foot
Consensus
Guidelines
Education

Keywords

  • Onychomycosis
  • Prevention
  • Recurrence
  • Risk factors

ASJC Scopus subject areas

  • Dermatology
  • Infectious Diseases

Cite this

Patients at risk of onychomycosis - Risk factor identification and active prevention. / Tosti, Antonella; Hay, R.; Arenas-Guzmán, R.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 19, No. SUPPL. 1, 01.09.2005, p. 13-16.

Research output: Contribution to journalArticle

@article{af5e642647214cae8acda63566519a65,
title = "Patients at risk of onychomycosis - Risk factor identification and active prevention",
abstract = "Objectives: The aims of this workshop were to identify risk factors for onychomycosis and to reach consensus on the management of high-risk groups to allow the development of guidelines to help doctors recognize risk factors that complicate treatment. Results and Conclusions: Previous Trichophyton rubrum infection, older age, abnormal nail morphology, immunodeficiency and genetic factors were identified as risk factors for initial infections. Risk factors for recurrence (relapse and re-infection) are largely the same. The experts agreed that the prevention of onychomycosis and its recurrence should be based on the correct treatment of tinea pedis, screening family members and adequate patient education. In addition, generic management recommendations for each high-risk group were discussed: Immunosuppressed patients Usual dose and treatment length not appropriate Follow-up required Beware of drug interactions Diabetics Prophylactic foot care combined with nail treatment Good opportunity for patient education, footwear, foot care, etc. Beware of drug interactions Psoriatics and patients with abnormal nails Dermatophyte eradication does not restore normal nails Children High failure rate possibly due to compliance problems.",
keywords = "Onychomycosis, Prevention, Recurrence, Risk factors",
author = "Antonella Tosti and R. Hay and R. Arenas-Guzm{\'a}n",
year = "2005",
month = "9",
day = "1",
doi = "10.1111/j.1468-3083.2005.01282.x",
language = "English",
volume = "19",
pages = "13--16",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Patients at risk of onychomycosis - Risk factor identification and active prevention

AU - Tosti, Antonella

AU - Hay, R.

AU - Arenas-Guzmán, R.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Objectives: The aims of this workshop were to identify risk factors for onychomycosis and to reach consensus on the management of high-risk groups to allow the development of guidelines to help doctors recognize risk factors that complicate treatment. Results and Conclusions: Previous Trichophyton rubrum infection, older age, abnormal nail morphology, immunodeficiency and genetic factors were identified as risk factors for initial infections. Risk factors for recurrence (relapse and re-infection) are largely the same. The experts agreed that the prevention of onychomycosis and its recurrence should be based on the correct treatment of tinea pedis, screening family members and adequate patient education. In addition, generic management recommendations for each high-risk group were discussed: Immunosuppressed patients Usual dose and treatment length not appropriate Follow-up required Beware of drug interactions Diabetics Prophylactic foot care combined with nail treatment Good opportunity for patient education, footwear, foot care, etc. Beware of drug interactions Psoriatics and patients with abnormal nails Dermatophyte eradication does not restore normal nails Children High failure rate possibly due to compliance problems.

AB - Objectives: The aims of this workshop were to identify risk factors for onychomycosis and to reach consensus on the management of high-risk groups to allow the development of guidelines to help doctors recognize risk factors that complicate treatment. Results and Conclusions: Previous Trichophyton rubrum infection, older age, abnormal nail morphology, immunodeficiency and genetic factors were identified as risk factors for initial infections. Risk factors for recurrence (relapse and re-infection) are largely the same. The experts agreed that the prevention of onychomycosis and its recurrence should be based on the correct treatment of tinea pedis, screening family members and adequate patient education. In addition, generic management recommendations for each high-risk group were discussed: Immunosuppressed patients Usual dose and treatment length not appropriate Follow-up required Beware of drug interactions Diabetics Prophylactic foot care combined with nail treatment Good opportunity for patient education, footwear, foot care, etc. Beware of drug interactions Psoriatics and patients with abnormal nails Dermatophyte eradication does not restore normal nails Children High failure rate possibly due to compliance problems.

KW - Onychomycosis

KW - Prevention

KW - Recurrence

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=28444476968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28444476968&partnerID=8YFLogxK

U2 - 10.1111/j.1468-3083.2005.01282.x

DO - 10.1111/j.1468-3083.2005.01282.x

M3 - Article

C2 - 16120200

AN - SCOPUS:28444476968

VL - 19

SP - 13

EP - 16

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - SUPPL. 1

ER -